Rebecca Siu Ga Tan

Rebecca Siu Ga Tan

Auto-generated profile, based on publicly available information

Rebecca Siu Ga Tan

Department of Physiology University of Alberta Edmonton Alberta Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2021 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
RTRebecca Siu Ga Tan
Rebecca Siu Ga Tan
CLChristy Hui Lin Lee
Christy Hui Lin Lee
HDHenrik Dimke
Henrik Dimke
RAR. Todd Alexander
R. Todd Alexander
The calcium-sensing receptor (CaSR) plays a critical role in sensing extracellular calcium (Ca2+) and signaling to maintain Ca2+homeostasis. In the parathyroid, the CaSR regulates secretion of parathyroid hormone, which functions to increase extracellular Ca2+levels. The CaSR is also located in other organs imperative to Ca2+homeostasis including the kidney and intestine, where it modulates Ca2+reabsorption and absorption, respectively. In this review, we describe CaSR expression and its function in transepithelial Ca2+transport in the kidney and intestine. Activation of the CaSR leads to G protein dependent and independent signaling cascades. The known CaSR signal transduction pathways involved in modulating paracellular and transcellular epithelial Ca2+transport are discussed. Mutations in the CaSR cause a range of diseases that manifest in altered serum Ca2+levels. Gain-of-function mutations in the CaSR result in autosomal dominant hypocalcemia type 1, while loss-of-function mutations cause familial hypocalciuric hypercalcemia. Additionally, the putative serine protease, FAM111A, is discussed as a potential regulator of the CaSR because mutations in FAM111A cause Kenny Caffey syndrome type 2, gracile bone dysplasia, and osteocraniostenosis, diseases that are characterized by hypocalcemia, hypoparathyroidism, and bony abnormalities, i.e. share phenotypic features of autosomal dominant hypocalcemia. Recent work has helped to elucidate the effect of CaSR signaling cascades on downstream proteins involved in Ca2+transport across renal and intestinal epithelia; however, much remains to be discovered.

1 May 2021 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
PFPatrícia G. Ferreira
Patrícia G. Ferreira
WMWouter H. van Megen
Wouter H. van Megen
RTRebecca Tan
Rebecca Tan
CLChristy H. L. Lee
Christy H. L. Lee
PSPer Svenningsen
Per Svenningsen
HDHenrik Dimke
Henrik Dimke
Using transgenic models and in vitro assays, this study examined the effect of Mg2+ on regulating urinary excretion of Ca2+ and Mg2+ via activation of the Ca2+-sensing receptor-claudin 14 (CLDN14) pathway. The study suggests that CLDN14 is unlikely to play a significant role in the compensatory response to hypermagnesemia.

2 May 2024 in Physiological Reports
Verified
Journal Article
Open access
RTRebecca Siu Ga Tan
Rebecca Siu Ga Tan
CLChristy Hui Lin Lee
Christy Hui Lin Lee
WPWanling Pan
Wanling Pan
SWSerene Wohlgemuth
Serene Wohlgemuth
MDMichael R. Doschak
Michael R. Doschak
RAR. Todd Alexander
R. Todd Alexander
FAM111A gene mutations cause Kenney–Caffey syndrome (KCS) and Osteocraniostenosis (OCS), conditions characterized by short stature, low serum ionized calcium (Ca2+), low parathyroid hormone (PTH), and bony abnormalities. The molecular mechanism mediating this phenotype is unknown. The c‐terminal domain of FAM111A harbors all the known disease‐causing variations and encodes a domain with high homology to serine proteases. However, whether this serine protease domain contributes to the maintenance of Ca2+ homeostasis is not known. We hypothesized the disruption of the serine protease domain of FAM111A would disrupt Ca2+ homeostasis. To test this hypothesis, we generated with CRISPR/Cas9, mice with a frameshift insertion (c.1450insA) or large deletion (c.1253‐1464del) mutation in the Fam111a serine protease domain. Serum‐ionized Ca2+ and PTH levels were not significantly different between wild type, heterozygous, or homozygous Fam111a mutant mice. Additionally, there were no significant differences in fecal or urine Ca2+ excretion, intestinal Ca2+ absorption or overall Ca2+ balance. Only female homozygous (c.1450insA), but not heterozygous mice displayed differences in bone microarchitecture and mineral density compared to wild‐type animals. We conclude that frameshift mutations that disrupt the c‐terminal serine protease domain do not induce a KCS or OCS phenotype in mice nor alter Ca2+ homeostasis.